As a science-based and patient-oriented healthcare company, we strive to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis is focused on three divisions with global scale and innovation power – pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
Pharmaceuticals develops innovative, patent-protected medicines to enhance health outcomes for patients and health-care providers. The division is at the forefront of development and commercialization in oncology, primary care and specialty medicines.
Alcon provides innovative products that enhance quality of life by helping people worldwide see better. Its three businesses – Surgical, Ophthalmic Pharmaceuticals and Vision Care – offer the world's widest spectrum of eye care products.
Sandoz is a global leader in the rapidly growing generics industry. Its products – which are focused in Retail Generics, Biopharmaceuticals & Oncology Injectables, and Anti-Infectives – help make affordable, high-quality medicines available to more people.